SCHEMBL8097310

SCHEMBL8097310

O=C(O)C1(c2ccc([N+](=O)[O-])cc2[N+](=O)[O-])CCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.47
ALDH1A1 P00352 3/20 0.46
MAPK1 P28482 2/20 0.46
GPR35 Q9HC97 2/20 0.46
TP53 P04637 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MAPT P10636 4/20 0.46
POLB P06746 2/20 0.46
NPSR1 Q6W5P4 3/20 0.46
TDP1 Q9NUW8 2/20 0.44
CES2 O00748 1/20 0.43
HIF1A Q16665 1/20 0.42
GAA P10253 2/20 0.42
TXNRD1 Q16881 1/20 0.41
TXNRD3 Q86VQ6 1/20 0.41
TXNRD2 Q9NNW7 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17241125 0.94 CYP1A2 (0.49) CYP1A2ALDH1A1MAPK1GPR35TP53
SCHEMBL5368690 0.81 AKR1C1 (0.49) CYP1A2ALDH1A1MAPK1GPR35TSHR
SCHEMBL27491469 0.81 HSD17B10 (0.47) CYP1A2ALDH1A1MAPK1TP53TSHR
SCHEMBL17241250 0.81 ALDH1A1 (0.47) CYP1A2ALDH1A1MAPK1GPR35TP53
SCHEMBL30937544 0.76 AKR1C1 (0.46) CYP1A2ALDH1A1MAPK1GPR35TSHR
SCHEMBL5369495 0.76 AKR1C1 (0.46) CYP1A2ALDH1A1MAPK1GPR35TSHR
SCHEMBL3224174 0.76 NPSR1 (0.55) CYP1A2ALDH1A1TSHRMAPTNPSR1
SCHEMBL17241148 0.75 CYP1A2 (0.52) CYP1A2ALDH1A1MAPK1GPR35TP53
SCHEMBL6676255 0.75 AKR1C1 (0.53) CYP1A2ALDH1A1TP53TSHRSMN1; SMN2
SCHEMBL27256523 0.74 BACE2 (0.38) CYP1A2ALDH1A1TSHRSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6124354-A TREATMENT OF URINARY INCONTINENCE OR IRRITABLE BOWEL SYNDROME PHARMACIA & UPJOHN AB (SE) 2000-09-26 US disclosed
EP-0923536-A1 ARYLCYCLOALKANE CARBOXYLIC ESTERS, THEIR USE, PHARMACEUTICAL COMPOSITIONS AND PREPARATION Pharmacia & Upjohn Aktiebolag (SE) 1999-06-23 EP disclosed
WO-1998004517-A1 ARYLCYCLOALKANE CARBOXYLIC ESTERS, THEIR USE, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PHARMACIA & UPJOHN AB (SE) 1998-02-05 WO disclosed